Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
2001 3
2002 1
2003 6
2004 2
2005 5
2006 2
2008 1
2009 1
2011 1
2014 1
2015 2
2017 1
2018 3
2019 2
2021 6
2022 2
2023 2
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.
Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, Groen HJ, McRae SE, Widder J, Feng L, van den Borne BE, Munsell MF, Hurkmans C, Berry DA, van Werkhoven E, Kresl JJ, Dingemans AM, Dawood O, Haasbeek CJ, Carpenter LS, De Jaeger K, Komaki R, Slotman BJ, Smit EF, Roth JA. Chang JY, et al. Among authors: de jaeger k. Lancet Oncol. 2015 Jun;16(6):630-7. doi: 10.1016/S1470-2045(15)70168-3. Epub 2015 May 13. Lancet Oncol. 2015. PMID: 25981812 Free PMC article. Clinical Trial.
Real-World Acute Toxicity and 90-Day Mortality in Patients With Stage I NSCLC Treated With Stereotactic Body Radiotherapy.
van Rossum PSN, Wolfhagen N, van Bockel LW, Coremans IEM, van Es CA, van der Geest AM, De Jaeger KEA, Wachters B, Knol HP, Koppe FLA, Pomp J, Reymen BJT, Schinagl DAX, Spoelstra FOB, Tissing-Tan CJA, Peters M, van der Voort van Zijp NCMG, van der Wel AM, Wiegman EM, Wijsman R, Damhuis RAM, Belderbos JSA. van Rossum PSN, et al. Among authors: de jaeger kea. J Thorac Oncol. 2024 Nov;19(11):1550-1563. doi: 10.1016/j.jtho.2024.07.016. Epub 2024 Jul 25. J Thorac Oncol. 2024. PMID: 39067700 Free article.
Quality of life after patient-initiated vs physician-initiated response to symptom monitoring: the SYMPRO-Lung trial.
Billingy NE, Tromp VNMF, Aaronson NK, Hoek RJA, Bogaard HJ, Onwuteaka-Philipsen BD, van de Poll-Franse L, Hugtenburg JG, Belderbos J, Becker-Commissaris A, van den Hurk CJG, Walraven I; SYMPRO-Lung Consortium. Billingy NE, et al. J Natl Cancer Inst. 2023 Dec 6;115(12):1515-1525. doi: 10.1093/jnci/djad159. J Natl Cancer Inst. 2023. PMID: 37603720 Free PMC article. Clinical Trial.
Why Did the Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC Not Reveal a Difference?
Belderbos JSA, De Ruysscher DKM, De Jaeger K, Koppe F, Lambrecht MLF, Lievens Y, Dieleman EMT, Jaspers JPM, Van Meerbeeck JP, Ubbels F, Kwint M, Kuenen M, Deprez S, De Ruiter MB, Boogerd W, Sikorska K, Van Tinteren H, Schagen SB. Belderbos JSA, et al. Among authors: de jaeger k. J Thorac Oncol. 2021 Jun;16(6):e42-e45. doi: 10.1016/j.jtho.2021.03.015. J Thorac Oncol. 2021. PMID: 34034890 Free article. No abstract available.
Reaction on the Interpretation of the Hippocampus Avoidance Prophylactic Cranial Irradiation Trial in SCLC (NCT01780675).
Belderbos JSA, De Ruysscher DKM, De Jaeger K, Koppe F, Lambrecht MLF, Lievens YN, Dieleman EMT, Jaspers JPM, Van Meerbeeck JP, Ubbels F, Kwint MH, Kuenen MA, Deprez S, De Ruiter MB, Boogerd W, Sikorska K, Van Tinteren H, Schagen SB. Belderbos JSA, et al. Among authors: de jaeger k. J Thorac Oncol. 2021 Aug;16(8):e63-e65. doi: 10.1016/j.jtho.2021.06.010. J Thorac Oncol. 2021. PMID: 34304858 Free article. No abstract available.
A taskforce for national improvement of innovation implementation in radiotherapy.
Jacobs M, Martinussen H, Swart R, Gubbels A, Dirkx M, de Boer H, Speijer G, Mondriaan K, de Jaeger K, Cuijpers J, Mast M, de Vreugt F, Boersma L. Jacobs M, et al. Among authors: de jaeger k. Radiother Oncol. 2024 Mar;192:110105. doi: 10.1016/j.radonc.2024.110105. Epub 2024 Jan 18. Radiother Oncol. 2024. PMID: 38244780 Free article.
Corrigendum to "Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands" [Lung Cancer 162C (2021) 61-70].
Evers J, Hendriks LEL, De Jaeger K, Wijsman R, De Ruysscher D, Terhaard C, van der Sangen M, Siesling S, Struikmans H, Aarts MJ. Evers J, et al. Among authors: de jaeger k. Lung Cancer. 2022 May;167:107. doi: 10.1016/j.lungcan.2021.12.012. Epub 2021 Dec 29. Lung Cancer. 2022. PMID: 34973817 No abstract available.
Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675).
Belderbos JSA, De Ruysscher DKM, De Jaeger K, Koppe F, Lambrecht MLF, Lievens YN, Dieleman EMT, Jaspers JPM, Van Meerbeeck JP, Ubbels F, Kwint MH, Kuenen MA, Deprez S, De Ruiter MB, Boogerd W, Sikorska K, Van Tinteren H, Schagen SB. Belderbos JSA, et al. Among authors: de jaeger k. J Thorac Oncol. 2021 May;16(5):840-849. doi: 10.1016/j.jtho.2020.12.024. Epub 2021 Feb 2. J Thorac Oncol. 2021. PMID: 33545387 Free article. Clinical Trial.
pH, hypoxia and metastasis.
Hill RP, De Jaeger K, Jang A, Cairns R. Hill RP, et al. Among authors: de jaeger k. Novartis Found Symp. 2001;240:154-65; discussion 165-8. doi: 10.1002/0470868716.ch11. Novartis Found Symp. 2001. PMID: 11727927 Review.
43 results